MX2015010190A - Metodos de tratamiento topico para infecciones microbianas. - Google Patents
Metodos de tratamiento topico para infecciones microbianas.Info
- Publication number
- MX2015010190A MX2015010190A MX2015010190A MX2015010190A MX2015010190A MX 2015010190 A MX2015010190 A MX 2015010190A MX 2015010190 A MX2015010190 A MX 2015010190A MX 2015010190 A MX2015010190 A MX 2015010190A MX 2015010190 A MX2015010190 A MX 2015010190A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- microbial infections
- topical microbial
- treating topical
- treating
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 239000004721 Polyphenylene oxide Substances 0.000 abstract 1
- 239000002555 ionophore Substances 0.000 abstract 1
- 230000000236 ionophoric effect Effects 0.000 abstract 1
- 229920000570 polyether Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención es un método y una composición para el tratamiento de una infección microbiana tópica en un sujeto. El método incluye la etapa de administrar una cantidad terapéuticamente efectiva de un poliéter inóforo, o una sal terapéuticamente aceptable del mismo, para el sujeto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013900412A AU2013900412A0 (en) | 2013-02-08 | Methods Of Treating Microbial Infections, Including Skin Infections | |
PCT/AU2014/000101 WO2014121342A1 (en) | 2013-02-08 | 2014-02-10 | Methods of treating topical microbial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015010190A true MX2015010190A (es) | 2016-08-03 |
MX359921B MX359921B (es) | 2018-10-16 |
Family
ID=51299090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015010190A MX359921B (es) | 2013-02-08 | 2014-02-10 | Métodos de tratamiento tópico para infecciones microbianas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9943500B2 (es) |
EP (1) | EP2953623B1 (es) |
JP (1) | JP2016507532A (es) |
KR (1) | KR20150119007A (es) |
CN (3) | CN111905104A (es) |
AU (1) | AU2014214547B2 (es) |
CA (1) | CA2900372C (es) |
HK (1) | HK1216389A1 (es) |
MX (1) | MX359921B (es) |
RU (1) | RU2675360C2 (es) |
WO (1) | WO2014121342A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2015314287B2 (en) | 2014-09-12 | 2019-04-18 | UNION therapeutics A/S | Antibacterial use of halogenated salicylanilides |
TWI656872B (zh) * | 2014-11-13 | 2019-04-21 | 美商益農美國公司 | 甲基鹽黴素於豬飼料中之抗病毒效果 |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
CN105218562A (zh) * | 2015-09-30 | 2016-01-06 | 浙江汇能动物药品有限公司 | 一种d(-)-磺苄西林钠的制备方法 |
CN109789125B (zh) * | 2016-08-16 | 2022-10-18 | 罗切斯特大学 | 含有基于多粘菌素b/甲氧苄啶的治疗剂的药物组合物 |
EP3554254A1 (en) | 2016-12-15 | 2019-10-23 | Société des Produits Nestlé S.A. | Compositions and methods that modulate bacteria in a companion animal |
CN106693924B (zh) * | 2016-12-16 | 2019-06-11 | 昆明理工大学 | 一种纳米二氧化硅吸附剂、制备方法及其应用 |
CN106943349B (zh) * | 2017-04-21 | 2020-12-11 | 华南农业大学 | 一种泰地罗新混悬注射液及其制备方法 |
IT201700060645A1 (it) * | 2017-06-01 | 2018-12-01 | Abiogen Pharma Spa | Uso di xibornolo come agente attivo nel trattamento dell’acne volgare |
CN108977481B (zh) * | 2017-11-08 | 2021-08-27 | 北大方正集团有限公司 | 一种发酵生产麦白霉素的方法 |
CN108165511B (zh) * | 2018-01-22 | 2020-11-20 | 四川农业大学 | 一种筛选培养基及制备方法和应用与微生物的筛选培养方法 |
CN108403676B (zh) * | 2018-03-20 | 2020-08-21 | 中山大学 | 琥珀酸在提高细菌对抗生素敏感性方面的应用 |
CN108663463A (zh) * | 2018-08-16 | 2018-10-16 | 齐鲁动物保健品有限公司 | 一种泰地罗新的含量检测方法 |
US11318149B2 (en) * | 2018-09-27 | 2022-05-03 | Board Of Trustees Of Michigan State University | Compositions and methods for inhibiting biofilm-forming bacteria |
CN111195246A (zh) * | 2018-11-16 | 2020-05-26 | 广西医科大学 | 聚醚类抗生素k-41b、k-41a在制备治疗或预防艾滋病毒药物中的应用 |
CN109452294B (zh) * | 2018-12-05 | 2022-05-17 | 北京市农林科学院 | 一种防控瓜类细菌性果斑病的方法及其专用种子杀菌剂 |
EP3894018A4 (en) * | 2018-12-11 | 2022-11-02 | Glyciome, LLC | TOPICAL, ISOTONIC COMPOSITIONS FOR GENITAL USE |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
CN109806273B (zh) * | 2019-03-05 | 2021-07-02 | 艾美科健(中国)生物医药有限公司 | 泰拉霉素和加米霉素的复合溶液剂及其制备方法与应用 |
WO2020216770A1 (en) * | 2019-04-24 | 2020-10-29 | Unilever Plc | Antimicrobial compositions |
CN110172524B (zh) * | 2019-06-05 | 2021-06-11 | 华中农业大学 | 制定鸡产气荚膜梭菌对阿维拉霉素的耐药判定标准的方法 |
CN110128486B (zh) * | 2019-06-19 | 2022-12-02 | 常州齐晖药业有限公司 | 一种泰拉霉素的合成方法 |
CN110372729B (zh) * | 2019-08-06 | 2022-03-22 | 泊诺(天津)创新医药研究有限公司 | 一种氟氧头孢钠的精制方法 |
CN110865134A (zh) * | 2019-10-22 | 2020-03-06 | 河北远征药业有限公司 | 一种泰地罗新含量检测方法 |
CN111150876B (zh) * | 2020-01-06 | 2020-12-01 | 中国科学院长春应用化学研究所 | 耐药性可视化的创可贴及其制备方法 |
CN115135323A (zh) * | 2020-04-17 | 2022-09-30 | 深圳市药欣生物科技有限公司 | 药物组合物 |
CN113813283B (zh) * | 2020-06-19 | 2023-12-12 | 中山大学附属第六医院 | 一类化合物促皮肤损伤修复的用途 |
US11278709B1 (en) | 2021-03-12 | 2022-03-22 | Pocket Naloxone Corp. | Drug delivery device and methods for using same |
CN113318107B (zh) * | 2021-07-08 | 2022-07-12 | 中国科学院微生物研究所 | 一种含氮化合物在制备抗真菌药物中的应用 |
CN113712988A (zh) * | 2021-08-17 | 2021-11-30 | 塔里木大学 | 一种槲皮素-替米考星聚合物纳米微粒、其制备方法及应用 |
CN113975373A (zh) * | 2021-11-18 | 2022-01-28 | 宁波市眼科医院 | 眼用制剂 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2171966B1 (es) * | 1972-02-17 | 1975-03-14 | Pierrefitte Auby Sa | |
US3873693A (en) * | 1974-03-11 | 1975-03-25 | Squibb & Sons Inc | Ionomycin |
EP0200508B1 (en) * | 1985-04-27 | 1991-10-02 | Nitto Denko Corporation | Adhesive oral bandages and oral pharmaceutical preparations |
BG45570A1 (en) * | 1987-06-11 | 1989-07-14 | Stefan G Dundarov | Means for virus desease cure |
US5130139A (en) * | 1990-07-06 | 1992-07-14 | Alza Corporation | Reduction or prevention of skin irritation by drugs |
PT934075E (pt) * | 1996-06-20 | 2002-08-30 | Novartis Ag | Metodo para a prevencao e tratamento da mastite |
US7223416B2 (en) * | 1999-06-28 | 2007-05-29 | Minu, L.L.C. | Topical composition |
EP1086947A1 (en) * | 1999-09-01 | 2001-03-28 | Pfizer Products Inc. | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
ES2257336T3 (es) * | 1999-11-12 | 2006-08-01 | MERCK & CO., INC. | Derivados de diaril piperidil pirrol como agentes antiprotozoarios. |
CN1646124B (zh) * | 2002-04-22 | 2010-05-26 | 宝洁公司 | 具有锌离子载体性能的物质的使用 |
WO2006081327A2 (en) | 2005-01-25 | 2006-08-03 | University Of Vermont And State Agricultural College | Small molecules that reduce fungal growth |
WO2008075207A2 (en) | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
GB0709513D0 (en) * | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
US20120101056A1 (en) * | 2009-04-13 | 2012-04-26 | Apex Laboratories Private Limited | Medicinal Cream Made Using Framycetin Sulphate and Chitosan and a Process to Make the Same |
KR20170126031A (ko) * | 2012-11-13 | 2017-11-15 | 난트 홀딩스 아이피, 엘엘씨 | 칼슘 유동 작동제 및 이의 방법 |
-
2014
- 2014-02-10 CN CN202010493491.3A patent/CN111905104A/zh active Pending
- 2014-02-10 MX MX2015010190A patent/MX359921B/es active IP Right Grant
- 2014-02-10 JP JP2015556343A patent/JP2016507532A/ja active Pending
- 2014-02-10 EP EP14748579.1A patent/EP2953623B1/en active Active
- 2014-02-10 KR KR1020157024412A patent/KR20150119007A/ko not_active Application Discontinuation
- 2014-02-10 CN CN202110294501.5A patent/CN113144197A/zh active Pending
- 2014-02-10 CA CA2900372A patent/CA2900372C/en active Active
- 2014-02-10 US US14/766,232 patent/US9943500B2/en active Active
- 2014-02-10 CN CN201480019177.4A patent/CN105492004A/zh active Pending
- 2014-02-10 RU RU2015132212A patent/RU2675360C2/ru active
- 2014-02-10 WO PCT/AU2014/000101 patent/WO2014121342A1/en active Application Filing
- 2014-02-10 AU AU2014214547A patent/AU2014214547B2/en active Active
-
2016
- 2016-04-15 HK HK16104321.4A patent/HK1216389A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2953623A4 (en) | 2016-08-10 |
RU2675360C2 (ru) | 2018-12-19 |
AU2014214547A1 (en) | 2015-08-20 |
CN111905104A (zh) | 2020-11-10 |
KR20150119007A (ko) | 2015-10-23 |
CN113144197A (zh) | 2021-07-23 |
CA2900372A1 (en) | 2014-08-14 |
RU2015132212A (ru) | 2017-03-15 |
JP2016507532A (ja) | 2016-03-10 |
WO2014121342A9 (en) | 2016-09-09 |
HK1216389A1 (zh) | 2016-11-11 |
CA2900372C (en) | 2021-06-08 |
EP2953623B1 (en) | 2021-06-30 |
CN105492004A (zh) | 2016-04-13 |
US20160000748A1 (en) | 2016-01-07 |
AU2014214547B2 (en) | 2018-08-30 |
EP2953623A1 (en) | 2015-12-16 |
WO2014121342A1 (en) | 2014-08-14 |
MX359921B (es) | 2018-10-16 |
US9943500B2 (en) | 2018-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015010190A (es) | Metodos de tratamiento topico para infecciones microbianas. | |
MX2015010191A (es) | Metodos para tratar infecciones microbianas, incluyendo mastitis. | |
PH12019501197A1 (en) | Therapeutically active compounds and their methods of use | |
NZ713621A (en) | Compounds and methods of treating infections | |
ZA201708692B (en) | Antibacterial compounds | |
PH12016500207A1 (en) | Anti-infective compounds | |
EP4282479A3 (en) | Use of pridopidine to treat depression or anxiety | |
CY1122805T1 (el) | Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων | |
MX363678B (es) | Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas. | |
WO2015003355A3 (en) | Therapeutically active compounds and their methods of use | |
MX2016004741A (es) | Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico. | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
WO2014152437A3 (en) | Methods of use for an antimicrobial peptide | |
EA201690075A1 (ru) | Способ лечения внутриклеточной инфекции | |
MX2015012580A (es) | El uso de sdf-1 para atenuar la formacion de cicatrices. | |
MX363631B (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
IN2013MU03216A (es) | ||
UA113859C2 (xx) | Похідні спіротієнопіранпіперидину як антагоністи рецептора orl-1 для їх застосування при лікуванні алкогольної залежності та зловживання алкоголем | |
EA201690445A1 (ru) | Лечение рака | |
MX2016001912A (es) | Metodos para tratar infecciones oticas luego de la colocacion de un tubo de timpanostomia. | |
AU2013900412A0 (en) | Methods Of Treating Microbial Infections, Including Skin Infections | |
UA87249U (ru) | Гель для лечения ран во второй фазе раневого процесса | |
GR1008258B (el) | Οφθαλμικο σκευασμα ενος αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |